The University of Nottingham’s Clinical Translational Research Priority Group will promote the development of a more productive and widespread clinical translational research culture, as well as strengthening established centres of excellence in translational research. In particular, these include:

• Department of Health National Institute for Health Research (NIHR)Biomedical Research Units (BRUs) in respiratory disease, gastrointestinal disease and hearing research
• the Nottingham Collaboration for Leadership in Applied Health and Research Care (CLAHRC) in mental health, children and young people, primary care, and stroke rehabilitation 
• the Arthritis Research UK (ARUK) Pain Centre
• lead university, with Bath, Birmingham, University College London, Queen Mary University of London, Stirling and Edinburgh for £2.9M UKCRC Centre for Tobacco Control Studies and several associated projects, including smoking prevention trials  

The Priority Group will also stimulate the growth of other research teams which have the potential to develop critical mass in areas which have unmet clinical needs.

Research themes

The key research themes are:

• infection, particularly bacteriology and virology ─  with Drug Discovery Priority Group
• Drug discovery and molecular therapeutics ─ with Drug Discovery Priority Group
• Translational imaging, particularly MRI ─ Biomedical Imaging Priority Group
• Integrative animal and human physiology ─ new Clinical Research Facility
• Faculty Biomedical Research Platforms ─ MRI facilities; SPECT, PET and Optical Translational Imaging Platform; Deep Sequencing, Clinical Trials Unit; Drug Discovery; Biomedical Service Unit
• Epidemiology and Public Health - in particular, tobacco control

Key aims 

The main aims of this Priority Group are to:

• stimulate interdisciplinary research  development activities, breaking down barriers between basic and applied clinical and non-clinical scientists
• promote greater use of the Faculty of Medicine and Health Sciences’ investments in core facilities  to facilitate cutting-edge clinical translational research
• establish how the latest advances in biomedical and public health research  can be applied to healthcare practice and health promotion
• increase the clinical and public health impact of research across the University in partnership with NHS Trusts and industry

Key academic leads

• Academic Champion: Professor Ian Hall, Dean of the Faculty of Medical and Health Sciences
• Business Development Executive: Dr Huw Jones Jenkins